20-years-groundbreaking-banner-2

20 Years of Groundbreaking Cancer Research

The Anniversary Edition

In 1999, The Beljanski Foundation was created to help cure cancer the natural way. Since then, we have been dedicated to funding research for natural, non-toxic answers to cancer by continuing the work of accomplished French molecular biologist, Dr. Mirko Beljanski. For over 40 years, Dr. Beljanski studied the environmental impact on DNA replication and transcription and found ways to prevent the duplication of unregulated cells.

Our mission is to foster and develop scientific methods for diagnosis, prevention, treatment, alleviation and cure of cancer and other chronic diseases in a natural, safe, non-toxic way.

Over the last 20 years, we have sponsored numerous ground-breaking research programs with the hope to help thousands of people beat cancer naturally. We have been working relentlessly to establish partnerships with renowned academic entities and get all the results published in peer-reviewed papers. Here is the research we have already completed, and we are working endlessly to bring more scientifically proven data and research in 2020.

Cancer AnniversaryPRECANCEROUS CELLS

  • Rauwolfia vomitoria and Pao pereira reduce high PSA (prostate inflammation marker) levels in men

Rauwolfia vomitoria and Pao pereira significantly decreased PSA levels in men over a 12-month period, demonstrating the anti-inflammatory effect of extracts. This clinical study was conducted at Columbia University.

Paper: Two Herbal Extracts for Protecting Prostate Cell DNA. Burchill M. Integrative Medicine. 2010;9(2):32-36.

CANCEROUS CELLS

  • Rauwolfia vomitoria extract against prostate cancer

Rauwolfia vomitoria extract significantly inhibited the growth of cancer cells and caused the cycle of prostate lymph node cancer (LNCaP) to stop. The volume of the tumor decreased by up to 70% in a study on mice. This study was conducted at Columbia University.

Paper: Anti-prostate cancer activity of β-carboline alkaloid enriched extract from Rauwolfia vomitoria. Bemis DL, Capodice JL, Gorroochurn P, Katz AE, Buttyan R. International Journal of Oncology. 2006;29:1065- 1073.

  • Pao pereira extract against prostate cancer

In vivo, Pao pereira reduced tumor growth by up to 80%, inducing apoptosis of cancer cells. This study was conducted at Columbia University.

Paper:   β-Carboline Alkaloid-Enriched Extract from the Amazonian Rain Forest Tree Pao Pereira Suppresses Prostate Cancer Cells. Bemis DL, Capodice JL, Desai M, Katz AE, Buttyan R. Journal of the Society for Integrative Oncology. 2009;7(2):59-65.

  • Pao pereira extract against ovarian cancer

The Pao pereria plant extract increased carboplatin (chemotherapy) effects against ovarian cancer. In vivo, Pao pereira reduced tumor growth by 79% and decreased the volume of ascites by 55%. When Pao pereira was combined with carboplatin, tumor growth decreased by 97% and ascites were completely eliminated. This study was conducted at The University of Kansas Medical Center.

Paper: The plant extract of  Pao  pereira  potentiates  carboplatin effects against ovarian cancer. Yu J, Chen Q. Pharmaceutical Biology. 2014;52(1):36-43.

  • Rauwolfia vomitoria extract against ovarian cancer

Rauwolfia vomitoria inhibited ovarian cancer cells, both alone and then in combination with carboplatin (chemotherapy). When combined with carboplatin, tumor size decreased by up to 90% and ascites volume decreased by up to 97%. This study was conducted at The University of Kansas Medical Center.

Paper: Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Carboplatin Effects Against Ovarian Cancer. Yu J, Ma Y, Drisko J, Chen Q. Current Therapeutic Research. 2013;75:8-14.

  • Pao pereira extract against pancreatic cancer

Studies were conducted in vitro and in vivo, confirming that Pao pereira reduced the growth of pancreatic cancer tumors by up to 72%. This study was conducted at The University of Kansas Medical Center.

Paper: Inhibition of pancreatic cancer and potentiation of gemcitabine effects by the extract of Pao Pereira. Yu J, Drisko J, Chen Q. Oncology Reports. 2013;30(1):149-156.

  • Rauwolfia vomitoria extract against pancreatic cancer

When pancreatic cancer cells were no longer responding to gemcitabine (chemotherapy), but treated with Rauwolfia vomitoria, the number of these cells decreased by 53%. When treated with a combination of gemcitabine and Rauwolfia vomitoria, pancreatic cancer tumors decreased by 56%. This study was conducted at The University of Kansas Medical Center.

Paper: Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Gemcitabine Effects Against Pancreatic Cancer. Yu J, Chen Q. Integrative Cancer Therapies. 2014;13(3): 217-225.

ADVANCED CANCER CELLS

  • Pao pereira extract against advanced prostate cancer

Pao pereira is effective against advanced hormone resistant prostate cancer cells, and metastases. This study was conducted at Nanjing University in China.

Paper: Pao Pereira Extract Suppresses Castration-Resistant Prostate Cancer Cell Growth, Survival, and Invasion Through Inhibition of NFκB Signaling. Chang C, Zhao W, Xie B, et al. Integrative Cancer Therapies. 2014;13(3):217-225.

Woman with Cancer

CANCER STEM CELLS

  • Pao pereira extract against pancreatic cancer stem cells

Pao pereira reduced the pancreatic cancerous tumors formed by stem cells by up to 70%. This study was conducted at The University of Kansas Medical Center.

Paper: Extract of the Medicinal Plant Pao Pereira Inhibits Pancreatic Cancer Stem-Like Cell In Vitro and In Vivo. Dong R, Chen P, Chen Q. Integrative Cancer Therapies. 2018;17(4):1204-1215.

  • Rauwolfia vomitoria extract against pancreatic cancer stem cells

Rauwolfia vomitoria reduced the formation of pancreatic cancerous tumors induced by cancer stem cells. This study was conducted at The University of Kansas Medical Center.

Paper: Inhibition of pancreatic cancer stem cells by Rauwolfia vomitoria extract. Dong R, Chen P, Chen Q. Oncology Reports. 2018;40:3144-3154.

Dr. Beljanski

CHEMOTHERAPY WITH RNA FRAGMENTS

  • Immune support for white blood cells and platelets

Cancer patients who took Beljanski’s RNA Fragments while undergoing chemotherapy all recovered with a stronger immune system and avoided thrombocytopenia (low platelet counts). This clinical trial was conducted at Cancer Treatment Centers of America.

Paper: Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia. Levin RD, Daehler M, Grutsch JF, Hall JL, Gupta D, Lis CG. BMC Cancer. 2010;10(1):1-8.

Winning The War On Cancer

For more information on our research and the story of The Beljanski Foundation, read

Winning The War On Cancer: The Epic Journey Towards a Natural Cure (now also available in French)

To order the English edition visit here

To order the French edition visit here

The Beljanski Foundation, Inc. is a 501(c)(3) nonprofit organization. Contributions are tax deductible in United States to the extent allowed by law. Tax ID: 13-4086570.

NOVEMBER 9-10, 2019: ScHO Conference – NYC

Come visit us at the Science of Human Optimization wellness event in Manhattan this November!

Vice President of The Beljanski Foundation, Sylvie Beljanski, will present her new book “Winning the War on Cancer” at the conference at 1:00pm on Saturday and Sunday.

Stop by our booth to learn more about our latest research updates and meet Sylvie Beljanski to pick up your signed copy of her book!

We are giving away a few tickets for the ScHO conference on a first come, first served basis. Please send us an email at media@beljanski.org with your full name, address and the number of tickets you would like to receive and we will send your tickets by mail as soon as they are available.

Date:
November 9-10, 2019

Location:
Westin Times Square
270 W 43rd St
New York, NY 10036

Learn more: www.navelexpo.com
 

 

NOVEMBER 10-11, 2018: Navel Expo – NYC

Come visit us at the Navel Expo wellness event in Manhattan this November!

Vice President of The Beljanski Foundation, Sylvie Beljanski, will present her new book “Winning the War on Cancer” on Saturday and Sunday at 2:00pm.

Stop by our booth to learn more about our latest research updates and meet Sylvie Beljanski to pick up your signed copy of her book!

We are giving away a few tickets for Navel Expo on a first come, first served basis. Please send us an email at media@beljanski.org with your full name, address and the number of tickets you would like to receive and we will send your tickets by mail as soon as they are available.

Date:
November 10-11, 2018

Location:
Sheraton New York Times Square Hotel
811 7th Avenue 53rd Street
New York, NY 10019

Learn more: www.navelexpo.com

NOVEMBER 3-4, 2018: 13th Take Back Your Health Conference – Washington DC

We invite you to join us at the 13th Take Back Your Health Conference this November in Washington DC.  This event is geared towards helping empower attendees to live the life that they would like to, unhindered by the limitations of chronic disease.  Speakers will share life-changing information to help individuals prevent and reverse disease when implemented into a lifestyle with purpose.  Sylvie Beljanski, Vice President of The Beljanski Foundation will present her new book, Winning The War On Cancer: The Epic Journey Towards A Natural Cure on Saturday at 3:30pm.  Stop by booth # 2 to meet her, pick up your signed copy of her book, and to learn more about our latest research program on the Beljanski plant extracts on pancreatic cancer stem cells.

Date:November 3-4, 2018

Location:
The Westin Tysons Corner
7801 Leesburg Pike
Falls Church, VA 22043

Learn more: www.takebackyourhealthdc.com

All Green Teas are Not Equal in Anti-Cancer Effect

All Green Teas are Not Equal in Anti-Cancer Effect:  Research shows that a special green tea blend is more effective against breast cancer.

 

Results:

The results of a new study comparing the anti-cancer effects of several well-known teas has shown that a newly developed blend of green teas was superior at inhibiting the growth of two breast cancer cell lines, including one highly metastatic cell line. This blend combines four different green teas: Ceylon Green, Bi Lou Chun, Organic Gunpowder and Dragonwell.

Blend of teas selected by Mirko Beljanski

The anti-cancer potential of each of these teas was originally identified by Prof. M. Beljanski of the Pasteur Institute using the Oncotest, an assay he developed for detecting carcinogenic and anti-carcinogenic compounds. The new study confirms the activity of a combination of the four green teas against breast cancer cells.

Green teas have long been associated with anti-oxidant and anti-cancer benefits, but the new research shows that the activity of this specific combination stands out. When tested against other teas including Bigelow®, Kusmi®, and Lipton®, the four green tea blend had the most potent anti-cancer effect on the cultured breast cancer cells. Data in the figure below show the viability of the breast cancer cell lines after exposure to extracts of each of the teas tested (400 micrograms/ml). The green tea blend (OnkoTeaTM) was the best at reducing the number of breast cancer cells.

Onkotea and breast cancer

This research was conducted at a prominent medical center that has conducted many successful projects on behalf of The Beljanski Foundation.  Further research is planned to explore the effects of the green tea blend on other types of cancer.

DECEMBER 14-16, 2017: A4M 25th Annual World Congress

Calling all healthcare professionals!  Please join us at the A4M 25th Annual World Congress this December! Dr. John Hall, Senior Scientific Advisor at The Beljanski Foundation, will present “Immune Support for Chemotherapy” on Thursday, December 14th from 1:45pm – 2:30pm.

Date:
December 14-16, 2017
For Healthcare professionals only

Location:
Venetian and Palazzo Resort
3355 Las Vegas Blvd S
Las Vegas, NV 89109

A4M Map

Learn more: A4M 25th Annual World Congress

SEPTEMBER 10, 2017 – CIRIS 26th Annual Picnic, France

The French counterpart of The Beljanski Foundation in Europe, CIRIS, will be organizing its annual picnic in Saintes, France once again in 2017. The event is dedicated to give the unique opportunity to patients and their family to meet and share information in a casual and relaxed atmosphere.

DSC0029 1

Everyone is welcome!

Contact:
Association CIRIS
B.P. 09
17550 Dolus d’Oléron
Tel: 00 33 4 74 56 58 00

Date:
Sunday, September 10, 2017

Location:
Parc du Séminaire de Recouvrance
Allée du Séminaire
17100 Saintes, FRANCE

Screen Shot 2017-05-26 at 11.30.54 AM

 

Pao pereira: Beljanski’s name far too often usurped

By Sylvie Beljanski

The Beljanski Foundation has fostered a great deal of research utilizing specific alkaloids found in the bark and leaves of certain plants. Among them, flavopereirine, an alkaloid found in the bark of Pao pereira, has been found, through research, to combat the proliferation of cancer cells. The Beljanski Foundation’s research has shown that the greater the potency of this alkaloid, the greater the benefit.

At The Beljanski Foundation, we want to use only the highest concentration of Pao pereira. That is why an independent lab conduct analysis of other Pao pereira  products and their concentration of Flavopereirine (the key alkanoid in Pao pereira).

Therefore, a project was undertaken to compare a number of different dietary supplements on the market that contain and advertise Pao pereira.

Comparison of various dietary supplements containing Pao pereira:

The Beljanski Foundation procured nine samples of dietary supplements from the United States and Europe for comparison. The objective was to compare the levels of flavopereirine to see if the beneficial compound in the products were similar in content across several brands. The nine intact, sealed bottles, were submitted to the same independent laboratory for analysis. The test method used, High Performance Liquid Chromatography (HPLC), was the same for all samples tested. The unused portions of the samples were returned to The Beljanski Foundation to be examined visually. All samples were found to be intact and not discolored or damaged.

The results of the testing were quite dramatic in regard to the flavopereirine content in each sample. Among the nine samples tested, seven of the products showed values of less than 100 parts per million (ppm) and the two remaining samples exhibited results that were greater than 800 ppm. The samples and results of the comparison are as follows:

  1. Pau Pereira Rainforest Pharmacy (USA) ……………………………………….. 27 ppm
  2. PAO PEREIRA Laboratoire Janine Benoit (Spain) …………………………. 52 ppm
  3. Pao V® Natural Source International, Ltd (USA) ………………………….. 823 ppm
  4. Pao V “FM”® Natural Source International, Ltd (USA) ………………….. 962 ppm
  5. PP 40 Super Smart  (Luxembourg) ………………………………………………… 13 ppm
  6. PAO PEREIRA Tincture (1:4) Tropilab® (USA) ………………………………. 10 ppm
  7. PAO 140 Bonté Naturelle NL Distributors Corp (Canada) ….. ………… Below LOQ*
  8. PAU PEREIRA Dieti Natura SAE Group (Switzerland) …………….. …. Below LOQ*
  9. Pao Pereira 40 Botagenic® Premedica Health Resources, LLC (USA) Below LOQ*

* LOQ – Limit of Quantitation

The results from the independent laboratory were graphed to clearly show the vast difference in Pao pereira products sold on the market

To summarize

The information presented clearly indicates that the majority of Pao pereira products analyzed available on the market worldwide have limited amounts of flavopereirine, the beneficial alkaloid (< 100 ppm), unlike the two Natural Source International, Ltd. products (> 800 ppm). Remember that The Beljanski Foundation’s extensive research programs have showed the higher the level of flavopereirine alkaloid, the greater the benefit. Obviously, the other companies have cited the research of The Beljanski Foundation and used it to market their own products with no supporting data of their own, but they cannot be compared to Beljanski’s formulation, and should not claim to have the same properties and effects.

While I cannot offer a definite reason for the drastic differences in flavopereirine content in the various products tested, I would hypothesize that there may be differences in the manufacturing processes or in the materials used for production.

The research programs of The Beljanski Foundation have been conducted with materials supplied by Natural Source International Ltd., a company with principles based on quality and integrity, and also the only company to own the extraction patents developed by my father, Mirko Beljanski, PhD, and to respect the extraction methods and the quality he defined.

To sum up things up

Knowing what’s actually in your supplements is often a challenge. There may be a less expensive version but there is a reason it is less expensive and when you are dealing with your health you should not have to worry about the quality of what you are putting in your body.

Interview in “Wellness for Life” on Radio MD Stay Well

On December 2nd, Sylvie Beljanski was invited on Radio MD to join Wellness for Life, hosted by Susanne Bennett. Our Vice-President introduced the Foundation and talked about the plants extracts, Pao pereira and Rauwolfia vomitoria, used by the Beljanski Foundation in its research for the fight against cancer.

picture1

Sylvie Beljanski discussed about the progress made in Environmental Medicine thanks to these extracts, and presented the anti-cancer properties they possess. The promising results obtained regarding these botanical extracts constitute a significant advance in Environmental Medicine.

Listen the interview here.

Interview in the “Late Night Health” with Mark Alyn

markalyn_latenight_banner-1On August 29th, Sylvie Beljanski joined Late Night Health for a lively discussion on plant-based foods and Environmental medicine with Mark Alyn.

Late Night Health is a radio show dedicated to provide people with healthcare information covering a wide range of topics such as traditional, complementary, and alternative health issues that people can relate to.

Sylvie Beljanski introduced The Beljanski Foundation and discussed about the legacy of Mirko Beljanski. His early findings at the Pasteur Institute in France focused on the healing power of botanical extracts. Hence, the Beljanski Foundation, in partnership with prestigious American institutions, such as the Columbia University Medical Center and the University of Kansas Medical Center, bases their research on natural compounds with anti-cancer properties (Pao pereira and Rauwolfia vomitoria). The recent research in Environmental Medicine have shown promising results regarding patients diagnosed with cancer.

The promising results represent a significant breakthrough for the Environmental Medicine.

You can listen to the interview (two parts): Part 1   Part 2

Interview in “Hutch in the Morning” on WBTM

Sylvie Beljanski©The Beljanski Foundation, Inc.Sylvie Beljanski was interviewed by Dave “Hutch” Hutcheson on WBTM, in Hutch in the morning to talk about The Beljanski Foundation. Sylvie Beljanski introduced the Foundation and the studies they are conducting based on the research of Mirko Beljanski, considered as the father of Environmental Medicine. The Beljanski Foundation carries on the legacy of Mirko Beljanski by continuing the research against cancer.

You can listen to the interview here.